Septerna (SEPN) Cash from Financing Activities (2024 - 2026)
Septerna's (SEPN) quarterly Cash from Financing Activities came in at $333000.0 in Q1 2026, up 404.55% year-on-year from $66000.0 in Q1 2025, and down 67.38% quarter-over-quarter from $1.0 million in Q4 2025.
Septerna (SEPN) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Septerna's Cash from Financing Activities history runs 3 years deep, the most recent figure standing at $333000.0 for Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 404.55% year-over-year to $333000.0 in Q1 2026; TTM through Mar 2026 was $2.0 million, a 99.35% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 99.55% from the prior year.
- Cash from Financing Activities retreated to $333000.0 in Q1 2026 per SEPN's latest filing, from $1.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $304.2 million in Q4 2024 and bottomed at -$1.3 million in Q3 2024.
- The 3-year median for Cash from Financing Activities is $333000.0 (2026), against an average of $43.6 million.
- Across the five-year window, Cash from Financing Activities sank 99.66% in 2025 and jumped 404.55% in 2026, its largest moves.
- Year by year, Cash from Financing Activities stood at $304.2 million in 2024, then sank by 99.66% to $1.0 million in 2025, then sank by 67.38% to $333000.0 in 2026.
- Per Business Quant, the three latest SEPN Cash from Financing Activities figures stand at $333000.0 (Q1 2026), $1.0 million (Q4 2025), and $263000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 68.63 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 9,311.16 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 238.74 Mn |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | 333,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 333,000.00 |
| Mar 31, 2026 | 333,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 263,000.00 |
| Sep 30, 2025 | 263,000.00 |
| Jun 30, 2025 | 339,000.00 |
| Jun 30, 2025 | 339,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | 304.15 Mn |
| Dec 31, 2024 | 304.15 Mn |
| Sep 30, 2024 | -1.32 Mn |
| Sep 30, 2024 | -1.32 Mn |